0001209191-17-053994.txt : 20170926 0001209191-17-053994.hdr.sgml : 20170926 20170926164633 ACCESSION NUMBER: 0001209191-17-053994 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170925 FILED AS OF DATE: 20170926 DATE AS OF CHANGE: 20170926 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ho Peter Tai-Ching CENTRAL INDEX KEY: 0001619052 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35945 FILM NUMBER: 171102544 MAIL ADDRESS: STREET 1: C/O EPIZYME, INC. STREET 2: 400 TECHNOLOGY SQUARE, 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Epizyme, Inc. CENTRAL INDEX KEY: 0001571498 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261349956 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-229-5872 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-25 0 0001571498 Epizyme, Inc. EPZM 0001619052 Ho Peter Tai-Ching C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 0 1 0 0 Chief Development Officer Commons Stock, par value $0.0001 2017-09-25 4 M 0 15000 8.98 A 23123 D Commons Stock, par value $0.0001 2017-09-25 4 S 0 15000 16.8051 D 8123 D Common Stock, par value $0.0001 1000 I By Trust Common Stock, par value $0.0001 1000 I By Trust Stock Option (Right to Buy) 8.98 2017-09-25 4 M 0 15000 0.00 D 2026-02-07 Common Stock 15000 15725 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.70 per share to $17.00 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are held in a brokerage account jointly owned by the reporting person and his spouse. These shares are held in trust for the benefit of the reporting person's child. The reporting person's spouse is a trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. This option is fully vested. /a/ Adriana Sullivan, attorney-in-fact 2017-09-26